1,198
Views
0
CrossRef citations to date
0
Altmetric
Review

Domain architecture and protein–protein interactions regulate KDM5A recruitment to the chromatin

ORCID Icon & ORCID Icon
Article: 2268813 | Received 18 May 2023, Accepted 01 Oct 2023, Published online: 15 Oct 2023

References

  • Fisher CL, Fisher AG. Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr Opin Genet Dev. 2011 Apr;21(2):140–19. doi: 10.1016/J.GDE.2011.01.015
  • Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004 Dec;119(7):941–953. doi: 10.1016/j.cell.2004.12.012
  • Carnesecchi J, Forcet C, Zhang L, et al. ERRα induces H3K9 demethylation by LSD1 to promote cell invasion. Proc Natl Acad Sci U S A. 2017 Apr;114(15):3909–3914. doi: 10.1073/PNAS.1614664114/SUPPL_FILE/PNAS.1614664114.SD01.XLSX
  • Christensen J, Agger K, Cloos PAC, et al. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell. 2007;128(6):1063–1076. doi: 10.1016/j.cell.2007.02.003
  • Iwase S, Lan F, Bayliss P, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007 Mar;128(6):1077–1088. doi: 10.1016/J.CELL.2007.02.017
  • Klose RJ, Yan Q, Tothova Z, et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell. 2007 Mar;128(5):889–900. doi: 10.1016/J.CELL.2007.02.013
  • Lee MG, Norman J, Shilatifard A, et al. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell. 2007 Mar;128(5):877–887. doi: 10.1016/J.CELL.2007.02.004
  • Tahiliani M, Mei P, Fang R, et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature. 2007 May;447(7144):601–605. doi: 10.1038/NATURE05823
  • Defeo-Jones D, Huang PS, Jones RE, et al. Cloning of cDnas for cellular proteins that bind to the retinoblastoma gene product. Nature. 1991;352(6332):251–254. doi: 10.1038/352251a0
  • Benevolenskaya EV, Murray HL, Branton P, et al. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell. 2005;18(6). doi: 10.1016/j.molcel.2005.05.012
  • Beshiri ML, Holmes KB, Richter WF, et al. Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation. Proc Natl Acad Sci U S A. 2012 Nov;109(45):18499–18504. doi: 10.1073/pnas.1216724109
  • Chicas A, Kapoor A, Wang X, et al. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci U S A. 2012;109(23):8971–8976. doi: 10.1073/pnas.1119836109
  • Ge Z, Li W, Wang N, et al. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J. 2010 Feb;24(2):579–586. doi: 10.1096/FJ.09-140087
  • Liefke R, Oswald F, Alvarado C, et al. Histone demethylase KDM5A is an integral part of the core Notch–RBP-J repressor complex. Genes Dev. 2010 Mar;24(6):590–601. doi: 10.1101/gad.563210
  • Váraljai R, Islam ABMMK, Beshiri ML, et al. Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells. Genes Dev. 2015 Sep;29(17):1817–1834. doi: 10.1101/GAD.264036.115
  • Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep. 2015 Dec;16(12):1620–1639. doi: 10.15252/EMBR.201541113
  • Pavlenko E, Ruengeler T, Engel P, et al. Functions and interactions of mammalian KDM5 demethylases. Front Genet. 2022 Jul;13:906662. doi: 10.3389/fgene.2022.906662
  • Teng YC, Lee C-F, Li Y-S, et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 2013 Aug;73(15):4711–4721. doi: 10.1158/0008-5472.CAN-12-3165
  • Li L, Wang L, Song P, et al. Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis. Mol Cancer. 2014;13(1). doi: 10.1186/1476-4598-13-81
  • Spangle JM, Dreijerink K, Groner A, et al. PI3K/AKT signaling regulates H3K4 methylation in breast cancer. Cell Rep. 2016 Jun;15(12):2692–2704. doi: 10.1016/j.celrep.2016.05.046
  • Choi HJ, Joo H-S, Won H-Y, et al. Role of RBP2-induced ER and IGF1R-ErbB signaling in tamoxifen resistance in breast cancer. J Natl Cancer Inst. 2018 Apr;110(4):400–410. doi: 10.1093/JNCI/DJX207
  • Garcia TB, Uluisik RC, van Linden AA, et al. Increased HDAC activity and c-MYC expression mediate acquired resistance to WEE1 inhibition in acute leukemia. Front Oncol. 2020 Mar;10:296.
  • Yan H, Chen X, Zhang Q, et al. Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. PLoS One. 2011 Sep;6(9):e24397. doi: 10.1371/JOURNAL.PONE.0024397
  • Horton JR, Engstrom A, Zoeller EL, et al. Characterization of a linked Jumonji domain of the KDM5/JARID1 family of histone H3 lysine 4 demethylases. J Biol Chem. 2016 Feb;291(6):2631–2646. doi: 10.1074/JBC.M115.698449
  • Torres IO, Kuchenbecker KM, Nnadi CI, et al. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism. Nat Commun. 2015;6(1). doi: 10.1038/ncomms7204
  • Wang GG, Song J, Wang Z, et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature. 2009;459(7248):847–851. doi: 10.1038/nature08036
  • Tu S, Teng Y-C, Yuan C, et al. The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif. Nat Struct Mol Biol. 2008;15(4):419–421. doi: 10.1038/nsmb.1400
  • Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature. 1998 Feb;391(6670):859–865. doi: 10.1038/36038
  • Kim YW, Otterson GA, Kratzke RA, et al. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein. Mol Cell Biol. 1994 Nov;14(11):7256–7264. doi: 10.1128/MCB.14.11.7256
  • Palopoli N, Foutel NSG, Gibson TJ, et al. Short linear motif core and flanking regions modulate retinoblastoma protein binding affinity and specificity. Protein Eng Des Sel. 31(3): Oxford University Press:69–77. Mar. 1, 2018. 10.1093/protein/gzx068
  • Kumbhar R, Sanchez A, Perren J, et al. Poly(adp-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions. J Cell Bio. 2021;220(7). doi: 10.1083/jcb.202006149
  • Dorosz J, Kristensen LH, Aduri NG, et al. Molecular architecture of the Jumonji C family histone demethylase KDM5B. Sci Rep. 2019 Dec;9(1). doi: 10.1038/S41598-019-40573-Y
  • Petronikolou N, Longbotham JE, Fujimori DG. Extended recognition of the histone H3 tail by histone Demethylase KDM5A. Biochemistry. 2020;59(5). doi: 10.1021/acs.biochem.9b01036
  • Cui J, Quan M, Xie D, et al. A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism. Oncogene. 2019;39:(5):1140–1151. vol. 39, no. 5,. doi: 10.1038/s41388-019-1051-8
  • Dreval K, Lake RJ, Fan HY. HDAC1 negatively regulates selective mitotic chromatin binding of the Notch effector RBPJ in a KDM5A-dependent manner. Nucleic Acids Res. 2019 May;47(9):4521–4538. doi: 10.1093/nar/gkz178
  • Gong F, Clouaire T, Aguirrebengoa M, et al. Histone demethylase KDM5A regulates the ZMY ND8-NuRD chromatin remodeler to promote DNA repair. J Cell Bio. 2017 Jul;216(7):1959–1974. doi: 10.1083/jcb.201611135
  • Lee KY, Bang SW, Yoon SW, et al. Phosphorylation of ORC2 protein dissociates origin recognition complex from chromatin and replication origins. J Biol Chem. 2012 Apr;287(15):11891. doi: 10.1074/JBC.M111.338467
  • Oser MG, Sabet AH, Gao W, et al. The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis. Genes Dev. 2019;33(23–24):1718–1738. doi: 10.1101/gad.328336
  • Wang C, Wang J, Li J, et al. KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis. Cell Death Dis. 2016;7(8):e2335–e2335. doi: 10.1038/CDDIS.2016.238
  • DiTacchio L, Le HD, Vollmers C, et al. Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. Sci (1979). 2011;333(6051):1881–1885. doi: 10.1126/science.1206022
  • Lopez-Bigas N, Kisiel TA, DeWaal DC, et al. Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell. 2008 Aug;31(4):520–530. doi: 10.1016/J.MOLCEL.2008.08.004
  • Pasini D, Hansen KH, Christensen J, et al. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and polycomb-repressive complex 2. Genes Dev. 2008 May;22(10):1345–1355. doi: 10.1101/gad.470008
  • Xu S, Wang S, Xing S, et al. KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2. Blood Adv. 2021 Sep;5(17):3241–3253. doi: 10.1182/BLOODADVANCES.2020002819
  • Bonnici J, Oueini R, Salah E, et al. The catalytic domains of all human KDM5 JmjC demethylases catalyse N-methyl arginine demethylation. FEBS Lett. 2023;597(7):933–946. doi: 10.1002/1873-3468.14586
  • Ohguchi H, Park PMC, Wang T, et al. Lysine demethylase 5A is required for MYC driven transcription in multiple myeloma. Blood Cancer Discov. 2021 Jul;2(4):370–387. doi: 10.1158/2643-3230.BCD-20-0108
  • Brier ASB, Loft A, Madsen J, et al. The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation. Nucleic Acids Res. 2017 Feb;45(4):1743–1759. doi: 10.1093/NAR/GKW1156
  • Yoo J, Kim GW, Jeon YH, et al. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis. vol. 54, no. 12 Exp Mol Med. 2022;54(12):2107–2117. doi: 10.1038/s12276-022-00902-0
  • van Oevelen C, Wang J, Asp P, et al. A role for mammalian Sin3 in permanent gene silencing. Mol Cell. 2008;32(3):359–370. doi: 10.1016/j.molcel.2008.10.015
  • Kim DK, Jeong H, Bae J, et al. Aβ-induced mitochondrial dysfunction in neural progenitors controls KDM5A to influence neuronal differentiation. Exp Mol Med. 2022 Sep;54(9):1461–1471. doi: 10.1038/S12276-022-00841-W
  • Zargar ZU, Kimidi MR, Tyagi S. Dynamic site-specific recruitment of RBP2 by pocket protein p130 modulates H3K4 methylation on E2F-responsive promoters. Nucleic Acids Res. 2018 Jan;46(1):174–188. doi: 10.1093/nar/gkx961
  • Craig JM, Earle E, Canham P, et al. Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. Hum Mol Genet. 2003 Dec;12(23):3109–3121. doi: 10.1093/HMG/DDG330
  • Prasanth SG, Prasanth KV, Siddiqui K, et al. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J. 2004 Jul;23(13):2651–2663. doi: 10.1038/SJ.EMBOJ.7600255
  • Huang C, Cheng J, Bawa-Khalfe T, et al. Sumoylated ORC2 recruits a histone demethylase to regulate centromeric histone modification and genomic stability. Cell Rep. 2016 Apr;15(1):147–157. doi: 10.1016/j.celrep.2016.02.091
  • Wang WP, Tzeng T-Y, Wang J-Y, et al. The EP300, KDM5A, KDM6A and KDM6B chromatin regulators cooperate with KLF4 in the transcriptional activation of POU5F1. PLoS One. 2012 Dec;7(12):e52556. doi: 10.1371/journal.pone.0052556
  • Kong SY, Kim W, Lee HR, et al. The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells. FASEB J. 2018 Feb;32(2):1108–1119. doi: 10.1096/FJ.201700780R
  • Bennett CN, Ross SE, Longo KA, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem. 2002 Aug;277(34):30998–31004. doi: 10.1074/JBC.M204527200
  • Guo L, Guo YY, Li BY, et al. Histone demethylase KDM5A is transactivated by the transcription factor C/EBPβ and promotes preadipocyte differentiation by inhibiting Wnt/β-catenin signaling. J Biol Chem. 2019 Jun;294(24):9642–9654. doi: 10.1074/JBC.RA119.008419
  • Hou J, et al. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am J Transl Res. 2012;4(3):247. [Online]. Available:/pmc/articles/PMC3426386/ Accessed 12, 10, 2022
  • Paolicchi E, Crea F, Farrar WL, et al. Histone lysine demethylases in breast cancer. Crit Rev Oncol Hematol. 2013 May;86(2):97–103. doi: 10.1016/J.CRITREVONC.2012.11.008
  • Zeng J, Ge Z, Wang L, et al. The histone demethylase RBP2 is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology. 2010 Mar;138(3):981–992. doi: 10.1053/J.GASTRO.2009.10.004/ATTACHMENT/B76E5BE1-8DAA-4B32-B783-B2B185C95EA3/MMC1.PDF
  • Li S, Wu Z, Li Q, et al. The prognostic value of AT-Rich interaction domain (ARID) family members in patients with hepatocellular carcinoma. Evid Based Complement Alternat Med. 2022;2022:1–16. doi: 10.1155/2022/1150390
  • Yang GJ, Ko CN, Zhong HJ, et al. Structure-based discovery of a selective KDM5A inhibitor that exhibits anti-cancer activity via inducing cell cycle arrest and senescence in breast cancer cell lines. Cancers (Basel). 2019 Jan;11(1). doi: 10.3390/CANCERS11010092.
  • Feng T, Wang Y, Lang Y, et al. KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance. Mol Med Rep. 2017 Sep;16(3):3573–3580. doi: 10.3892/mmr.2017.6960
  • Hu D, Jablonowski C, Cheng P-H, et al. KDM5A regulates a translational Program that controls p53 protein expression. iScience. 2018;9:84–100. doi: 10.1016/j.isci.2018.10.012
  • De Rooij JDE, Hollink IHIM, Arentsen-Peters STCJM, et al. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia. 2013;27(12):2280–2288. doi: 10.1038/leu.2013.87
  • Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood. 2011 Dec;118(24):6247–6257. doi: 10.1182/BLOOD-2011-07-328880
  • Pineault N, Buske C, Feuring-Buske M, et al. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood. 2003 Jun;101(11):4529–4538. doi: 10.1182/BLOOD-2002-08-2484
  • Wang GG, Cai L, Pasillas MP, et al. NUP98-NSD1 links H3K36 methylation to hox-A gene activation and leukaemogenesis. Nat Cell Biol. 2007 Jul;9(7):804–812. doi: 10.1038/NCB1608
  • Liang X, Zeng J, Wang L, et al. Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212. PLoS One. 2013 Jul;8(7):e69784. doi: 10.1371/JOURNAL.PONE.0069784
  • Liu C, Zheng Z, Li W, et al. Inhibition of KDM5A attenuates cisplatin-induced hearing loss via regulation of the MAPK/AKT pathway. Cell Mol Life Sci. 2022 Dec;79(12). doi: 10.1007/S00018-022-04565-Y
  • Peng Y, Suryadi J, Yang Y, et al. Mutations in the KDM5C ARID domain and their plausible association with Syndromic Claes-Jensen-type disease. Int J Mol Sci. 2015 Nov;16(11):27270. doi: 10.3390/IJMS161126022
  • Ugur FS, Kelly MJS, Galonic´fujimori D, et al. Chromatin sensing by the Auxiliary domains of KDM5C regulates its demethylase activity and is disrupted by X-linked intellectual disability mutations. J Mol Biol. 2023;435(2):167913. doi: 10.1016/j.jmb.2022.167913
  • Miller J, McLachlan AD, Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from xenopus oocytes. EMBO J. 1985;4(6):1609–1614. doi: 10.1002/J.1460-2075.1985.TB03825.X
  • Hanas JS, Hazuda DJ, Bogenhagen DF, et al. Xenopus transcription RNA gene* factor a requires Zinc for binding to the 5 s. J Biol Chem. 1983;258(23):14120–14125. doi:10.1016/S0021-9258(17)43831-2
  • Zhang Y, Guo Y, Gough SM, et al. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion. Nat Commun. 2020 Dec;11(1). doi: 10.1038/S41467-020-17098-4
  • Liu X, Secombe J. The histone demethylase KDM5 activates gene expression by recognizing chromatin context through its PHD reader motif. Cell Rep. 2015;13(10):2219–2231. doi: 10.1016/J.CELREP.2015.11.007
  • Longbotham JE, Chio CM, Dharmarajan V, et al. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling. Nat Commun. 2019 Dec;10(1). doi: 10.1038/s41467-018-07829-z
  • Suganuma T, Workman JL. Crosstalk among histone modifications. Cell. 2008 Nov;135(4):604–607. doi: 10.1016/j.cell.2008.10.036
  • Hayakawa T, Ohtani Y, Hayakawa N, et al. RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. Genes Cells. 2007 Jun: 070606122915002–???. doi: 10.1111/j.1365-2443.2007.01089.x
  • Varier RA, de Santa Pau EC, van der Groep P, et al. Recruitment of the mammalian histone-modifying EMSY complex to target genes is regulated by ZNF131. J Biol Chem. 2016 Apr;291(14):7313–7324. doi: 10.1074/jbc.M115.701227
  • Chen PL, Scully P, Shew JY, et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 1989 Sep;58(6):1193–1198. doi: 10.1016/0092-8674(89)90517-5
  • Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. Aug. 28, 2006;25(38):5220–5227. doi: 10.1038/sj.onc.1209615
  • Roesch A, Becker B, Meyer S, et al. Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol. 2005 Sep;18(9):1249–1257. doi: 10.1038/MODPATHOL.3800413
  • Lin W, Cao J, Liu J, et al. Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc Natl Acad Sci U S A. 2011 Aug;108(33):13379–13386. doi: 10.1073/PNAS.1110104108
  • Canhoto AJ, Chestukhin A, Litovchick L, et al. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells. Oncogene. 2000;19(44):5116–5122. vol. 19, no. 44. doi: 10.1038/sj.onc.1203893.
  • Mayol X, Garriga J, Grana X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene. 1995 Aug [Accessed 16, Nov 2023];11(4):801–808. [Online]. Available: https://europepmc.org/article/med/7651744
  • Dephoure N, Zhou C, Villén J, et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug;105(31):10762. doi: 10.1073/PNAS.0805139105
  • Cole MD, Henriksson M. 25 years of the c-Myc oncogene. Semin Cancer Biol. 2006 Aug;16(4):241. doi: 10.1016/J.SEMCANCER.2006.08.003
  • McMahon SB, Van Buskirk HA, Dugan KA, et al. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 1998 Aug;94(3):363–374. doi: 10.1016/S0092-8674(00)81479-8
  • Nikiforov MA, Chandriani S, Park J, et al. TRRAP-Dependent and TRRAP-Independent transcriptional activation by Myc family oncoproteins. Mol Cell Biol. 2002 Jul;22(14):5054. doi: 10.1128/MCB.22.14.5054-5063.2002
  • Ayer DE, Lawrence QA, Eisenman RN. Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell. 1995 Mar;80(5):767–776. doi: 10.1016/0092-8674(95)90355-0
  • Secombe J, Eisenman RN. The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection. Cell Cycle. 2007 Jun;6(11):1324–1328. doi: 10.4161/CC.6.11.4269
  • Secombe J, Li L, Carlos L, et al. The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev. 2007 Mar;21(5):537. doi: 10.1101/GAD.1523007
  • Nishibuchi G, Shibata Y, Hayakawa T, et al. Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex. J Biol Chem. 2014 Oct;289(42):28956–28970. doi: 10.1074/JBC.M114.573725
  • Malovannaya A, Lanz R, Jung S, et al. Analysis of the human endogenous coregulator complexome. Cell. 2011 May;145(5):787–799. doi: 10.1016/J.CELL.2011.05.006
  • Gaillard S, Charasson V, Ribeyre C, et al. Kdm5a and kdm5b histone-demethylases contribute to hu-induced replication stress response and tolerance. Biol Open. 2021 May;10(5). doi: 10.1242/BIO.057729/268370
  • Zhao D, et al., ‘Erratum: H3K4me3 demethylase Kdm5a is required for NK cell activation by associating with p50 to suppress SOCS1 (cell reports (2016) 15(2) (288–299), ( S2211124716302911), (10.1016/j.celrep.2016.03.035), Cell Reports, vol. 30(7) Elsevier B.V, p. 2460, Feb. 18, 2020. doi: 10.1016/j.celrep.2020.01.104.
  • Manna S, Kumar Patra S, Samir Kumar Patra P. Physical association of functionally antagonistic enzymes: kDM5A interacts with MLLs to regulate gene expression in a promoter specific manner facilitating EMT and pluripotency. DOI:10.1101/2021.12.03.471073.
  • Yu X, Chen H, Zuo C, et al. Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation. FASEB J. 2018;32(2):552–567. doi: 10.1096/fj.201700088RR
  • Chan SW, Hong W. Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription *. J Biol Chem. 2001 Jul;276(30):28402–28412. M100313200. doi: 10.1074/jbc.M100313200